March was a particularly tough month for both the broad
markets and for hedge fund managers in general. The S&P 500
posted a 1.77% loss, which contributed to its quarterly loss of
2.15%. Fixed-income markets also finished the quarter with
losses, making it difficult for hedge fund managers to find
profitable investment opportunities. Some hedge funds took big
hits on pharmaceutical stocks, as two drug makers saw a
dramatic plunge in their...